These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. New conceptions of autoimmunity and of systemic lupus erythematosus. Bach JF; Bach MA; Tron F Adv Nephrol Necker Hosp; 1976; 6():5-35. PubMed ID: 139083 [No Abstract] [Full Text] [Related]
5. [Morphologic and immunomorphologic studies in rheumatoid arthritis and systemic lupus erythematosus]. Wagner T Patol Pol; 1984; 35(1):45-64. PubMed ID: 6333663 [No Abstract] [Full Text] [Related]
6. [Antibodies to extractable nuclear antigens in systemic lupus erythematosus]. Ivanova SM; Alekberova ZS; Preobrazhenskiĭ DV; Speranskiĭ AI Ter Arkh; 1982; 54(6):54-7. PubMed ID: 7112420 [No Abstract] [Full Text] [Related]
7. [Ultrastructural data on the immune-complex nature of vascular lesions in systemic lupus erythematosus]. Dreĭer EO; Alekberova ES; Mul'diiarov PIa; Nasonova VA Ter Arkh; 1980; 52(6):57-9. PubMed ID: 6447379 [No Abstract] [Full Text] [Related]
8. [Cellular and humoral factors of immunogenesis of sytemic lupus erythematosus and systemic scleroderma]. Demin AA; Galenok VA; Kolesnuk VV; Finchenko AF Klin Med (Mosk); 1973 Nov; 51(11):100-4. PubMed ID: 4787290 [No Abstract] [Full Text] [Related]
9. Interferons and immune reactivity. Hooks JJ; Detrick-Hooks B; Levinson AI J Am Vet Med Assoc; 1982 Nov; 181(10):1111-4. PubMed ID: 6184354 [No Abstract] [Full Text] [Related]
11. [A syndrome similar to that of lupus erythematosus with anti-mitochondrial antibodies]. Mass D; Schubothe H Minerva Med; 1973 Aug; 64(58):3009-20. PubMed ID: 4742640 [No Abstract] [Full Text] [Related]
12. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis. Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137 [TBL] [Abstract][Full Text] [Related]
13. [Functional analysis of immune complex-rich serum fractions in autoimmune diseases by in vitro C3 activation of fresh blood]. Böhm U; Merétey K; Falus A; Bozsóky S Z Rheumatol; 1981; 40(3):126-30. PubMed ID: 6456623 [TBL] [Abstract][Full Text] [Related]
14. Evaluation and clinical significance of circulating immune complexes. Theofilopoulos AN Prog Clin Immunol; 1980; 4():63-106. PubMed ID: 6247742 [No Abstract] [Full Text] [Related]
16. Platelet aggregation and cryo-IgM in the study of hepatitis and immune complex states. Penttinen K; Wager O; Räsänen JA; Myllylä G; Haapanen E Clin Exp Immunol; 1973 Nov; 15(3):409-16. PubMed ID: 4271773 [TBL] [Abstract][Full Text] [Related]
17. [Significance of DNAase activity of blood in systemic lupus erythematosus]. Klimov VIu Sov Med; 1974 Nov; (11):78-81. PubMed ID: 4280140 [No Abstract] [Full Text] [Related]
18. [Basis for and perspectives of using interferon in the treatment of systemic lupus erythematosus]. Siniachenko OV Ter Arkh; 1975; 47(11):134-8. PubMed ID: 1224298 [No Abstract] [Full Text] [Related]
19. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207 [TBL] [Abstract][Full Text] [Related]
20. Antinuclear antibodies are common in an infectious environment but do not predict systemic lupus erythematosus. Cainelli F; Betterle C; Vento S Ann Rheum Dis; 2004 Dec; 63(12):1707-8. PubMed ID: 15547107 [No Abstract] [Full Text] [Related] [Next] [New Search]